Literature DB >> 26286991

IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

Francesca Barone1, Saba Nayar2, Joana Campos2, Thomas Cloake2, David R Withers3, Kai-Michael Toellner3, Yang Zhang3, Lynette Fouser4, Benjamin Fisher2, Simon Bowman2, Javier Rangel-Moreno5, Maria de la Luz Garcia-Hernandez5, Troy D Randall6, Davide Lucchesi7, Michele Bombardieri7, Costantino Pitzalis7, Sanjiv A Luther8, Christopher D Buckley2.   

Abstract

The series of events leading to tertiary lymphoid organ (TLO) formation in mucosal organs following tissue damage remain unclear. Using a virus-induced model of autoantibody formation in the salivary glands of adult mice, we demonstrate that IL-22 provides a mechanistic link between mucosal infection, B-cell recruitment, and humoral autoimmunity. IL-22 receptor engagement is necessary and sufficient to promote differential expression of chemokine (C-X-C motif) ligand 12 and chemokine (C-X-C motif) ligand 13 in epithelial and fibroblastic stromal cells that, in turn, is pivotal for B-cell recruitment and organization of the TLOs. Accordingly, genetic and therapeutic blockade of IL-22 impairs and reverses TLO formation and autoantibody production. Our work highlights a critical role for IL-22 in TLO-induced pathology and provides a rationale for the use of IL-22-blocking agents in B-cell-mediated autoimmune conditions.

Entities:  

Keywords:  IL-22; Sjogren's syndrome; autoimmunity; chemokines; tertiary lymphoid organs

Mesh:

Substances:

Year:  2015        PMID: 26286991      PMCID: PMC4568258          DOI: 10.1073/pnas.1503315112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  B cells within germinal centers migrate preferentially from dark to light zone.

Authors:  Joost B Beltman; Christopher D C Allen; Jason G Cyster; Rob J de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

2.  Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.

Authors:  Francesco Ciccia; Antonina Accardo-Palumbo; Riccardo Alessandro; Aroldo Rizzo; Simona Principe; Sergio Peralta; Francesca Raiata; Annarita Giardina; Giacomo De Leo; Giovanni Triolo
Journal:  Arthritis Rheum       Date:  2011-12-27

3.  Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.

Authors:  Kyoung-Woon Kim; Hae-Rim Kim; Jin-Young Park; Jin-Sil Park; Hye-Jwa Oh; Yun-Ju Woo; Mi-Kyung Park; Mi-La Cho; Sang-Heon Lee
Journal:  Arthritis Rheum       Date:  2011-10-27

4.  Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters.

Authors:  T N Lavoie; C M Stewart; K M Berg; Y Li; C Q Nguyen
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

5.  CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.

Authors:  Gregory F Sonnenberg; Laurel A Monticelli; M Merle Elloso; Lynette A Fouser; David Artis
Journal:  Immunity       Date:  2010-12-30       Impact factor: 31.745

6.  IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium.

Authors:  Naruhisa Ota; Kit Wong; Patricia A Valdez; Yan Zheng; Natasha K Crellin; Lauri Diehl; Wenjun Ouyang
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

7.  Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.

Authors:  Stanislav Pantelyushin; Stefan Haak; Barbara Ingold; Paulina Kulig; Frank L Heppner; Alexander A Navarini; Burkhard Becher
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

8.  Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation.

Authors:  Anneli Peters; Lisa A Pitcher; Jenna M Sullivan; Meike Mitsdoerffer; Sophie E Acton; Bettina Franz; Kai Wucherpfennig; Shannon Turley; Michael C Carroll; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  Immunity       Date:  2011-12-15       Impact factor: 31.745

9.  The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

Authors:  Javier Rangel-Moreno; Damian M Carragher; Maria de la Luz Garcia-Hernandez; Ji Young Hwang; Kim Kusser; Louise Hartson; Jay K Kolls; Shabaana A Khader; Troy D Randall
Journal:  Nat Immunol       Date:  2011-06-12       Impact factor: 25.606

10.  Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.

Authors:  Frances Humby; Michele Bombardieri; Antonio Manzo; Stephen Kelly; Mark C Blades; Bruce Kirkham; Jo Spencer; Costantino Pitzalis
Journal:  PLoS Med       Date:  2009-01-13       Impact factor: 11.069

View more
  76 in total

Review 1.  Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity.

Authors:  Victor H Engelhard; Anthony B Rodriguez; Ileana S Mauldin; Amber N Woods; J David Peske; Craig L Slingluff
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 2.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Authors:  Medya M Shikhagaie; Kristine Germar; Suzanne M Bal; Xavier Romero Ros; Hergen Spits
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

Review 3.  Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.

Authors:  Michele Bombardieri; Myles Lewis; Costantino Pitzalis
Journal:  Nat Rev Rheumatol       Date:  2017-02-09       Impact factor: 20.543

Review 4.  Lymph node stromal cells: cartographers of the immune system.

Authors:  Akshay T Krishnamurty; Shannon J Turley
Journal:  Nat Immunol       Date:  2020-03-23       Impact factor: 25.606

5.  Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance.

Authors:  Wenjun Li; Jason M Gauthier; Alice Y Tong; Yuriko Terada; Ryuji Higashikubo; Christian C Frye; Margaret S Harrison; Kohei Hashimoto; Amit I Bery; Jon H Ritter; Ruben G Nava; Varun Puri; Brian W Wong; Kory J Lavine; Ankit Bharat; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 6.  Management of primary Sjögren's syndrome: recent developments and new classification criteria.

Authors:  Nicoletta Del Papa; Claudio Vitali
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-01-01       Impact factor: 5.346

Review 7.  IL-27: a double agent in the IL-6 family.

Authors:  G W Jones; D G Hill; A Cardus; S A Jones
Journal:  Clin Exp Immunol       Date:  2018-03-09       Impact factor: 4.330

Review 8.  The Role of Lymphoid Neogenesis in Allografts.

Authors:  H-M Hsiao; W Li; A E Gelman; A S Krupnick; D Kreisel
Journal:  Am J Transplant       Date:  2016-02-15       Impact factor: 8.086

Review 9.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

Review 10.  B cells in the pathogenesis of primary Sjögren syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.